Philippe Foubert
About Philippe Foubert
Philippe Foubert is the Director of Tumor Microenvironment Translational Biomarkers at Bristol Myers Squibb, with a strong background in regenerative medicine and oncology.
Current Role at Bristol Myers Squibb
Philippe Foubert currently holds the position of Director Tumor Microenvironment Translational Biomarkers at Bristol Myers Squibb. In this role, he leads efforts to develop and implement biomarkers that provide critical insights into the tumor microenvironment. His work in this capacity is focused on enhancing the translational research that bridges preclinical findings with clinical applications, especially in oncology.
Previous Experience at Atara Biotherapeutics
Before joining Bristol Myers Squibb, Philippe Foubert worked at Atara Biotherapeutics in the Greater Los Angeles Area for approximately two years. Initially, he served as Sr. Manager, Preclinical & Translational Science, from 2018 to 2019. Subsequently, he was promoted to Associate Director, Preclinical and Translational Science, a role he held from 2019 to 2020. During his tenure, he was instrumental in leading preclinical and translational science initiatives, contributing to both early and late-phase clinical trials.
Role at Cytori Therapeutics Inc
Philippe Foubert's career includes significant time at Cytori Therapeutics Inc in the Greater San Diego Area. He held multiple positions there: Scientist I from 2013 to 2014, Scientist II from 2014 to 2015, and Manager, Preclinical, Analytical Biology from 2015 to 2017. In these roles, he specialized in analytical biology and contributed to Chemistry, Manufacturing, and Controls (CMC) strategy, alongside extensive interactions with Contract Research Organizations (CROs) and academic institutions.
Academic Background and Postdoctoral Research
Philippe Foubert has a robust academic background. He completed his PhD in Biology and Pharmacology at Université Denis Diderot (Paris VII), focusing on Vascular Biology from 2003 to 2007. Following this, he completed postdoctoral research in Regenerative Medicine at the Genomics Institute of the Novartis Research Foundation in San Diego from 2011 to 2013. Previously, he was a Postdoctoral Scholar at Moores UCSD Cancer Center from 2008 to 2011, contributing to regenerative medicine and oncology research.
Expertise in Cell Therapy and Project Management
Philippe Foubert's professional expertise encompasses cell therapy, including significant project management and regulatory experience. His scientific background is particularly strong in regenerative medicine and oncology. He has led preclinical and translational science efforts, playing a key role in both the development and execution of clinical trials. His work involves close collaboration with CROs and academic institutions, ensuring the successful translation of scientific research into clinical applications.